solution à diluer pour de perfusion

DRUG2 trials

Sponsors

Groupe Oncologie Radiotherapie Tete Cou, Centre Hospitalier Universitaire De Toulouse

Conditions

Cervical CancerRecurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Phase 2

A phase II study evaluating the efficacy and the safety of TPEx followed by a maintenance with the combination of avelumab and cetuximab in First Line Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN).

SuspendedCTIS2023-510559-41-00

Groupe Oncologie Radiotherapie Tete CouRecurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Start: 2025-01-02Target: 70Updated: 2025-05-23

Phase 3

Induction chemotherapy followed by standard concurrent chemoradiotherapy in cervical cancer with para-aortic lymph node involvement: A phase III, multicenter, parallel-group randomized, controlled trial - ONCOCOL-01

SuspendedCTIS2024-513576-18-00

Centre Hospitalier Universitaire De ToulouseCervical Cancer

Start: 2020-07-17Target: 310Updated: 2024-08-12